Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain

NAUnknownINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

April 30, 2018

Study Completion Date

November 1, 2020

Conditions
Lupus Erythematosus, SystemicMusculoskeletal Pain
Interventions
DEVICE

Vagus nerve stimulation

Patients will receive transcutaneous stimulation of the auricular branch of the left vagus nerve for 5 minutes daily for 4 consecutive days. The device is a handheld electrical pulse generator and a pair of electrodes to be placed at the ear for stimulation. The specific target at the ear will be the auricular branch of the vagus nerve which innervates the skin of the ear canal. Electrodes will be placed near/at the entrance to the canal of the ear to provide stimulation to the auricular branch.

DEVICE

Sham vagus nerve stimulation

Patients will receive sham transcutaneous stimulation of the auricular branch of the left vagus nerve for 5 minutes daily for 4 consecutive days. Sham stimulation will be performed in the identical manner as true transcutaneous stimulation except that the patient will not receive electrical stimulation of the vagus nerve.

Trial Locations (1)

11030

Feinstein Institute, Manhasset

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

John and Marcia Goldman Foundation

UNKNOWN

lead

Northwell Health

OTHER

NCT02822989 - Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain | Biotech Hunter | Biotech Hunter